EquisetinCAS# 57749-43-6 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 57749-43-6 | SDF | Download SDF |
PubChem ID | 54684703 | Appearance | Powder |
Formula | C22H31NO4 | M.Wt | 373.49 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (3E,5S)-3-[[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(E)-prop-1-enyl]-4a,5,6,7,8,8a-hexahydro-2H-naphthalen-1-yl]-hydroxymethylidene]-5-(hydroxymethyl)-1-methylpyrrolidine-2,4-dione | ||
SMILES | CC=CC1C=CC2CC(CCC2C1(C)C(=C3C(=O)C(N(C3=O)C)CO)O)C | ||
Standard InChIKey | QNQBPPQLRODXET-AIMHRHHOSA-N | ||
Standard InChI | InChI=1S/C22H31NO4/c1-5-6-15-9-8-14-11-13(2)7-10-16(14)22(15,3)20(26)18-19(25)17(12-24)23(4)21(18)27/h5-6,8-9,13-17,24,26H,7,10-12H2,1-4H3/b6-5+,20-18+/t13-,14-,15-,16-,17+,22-/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Equisetin has antibacterial activity, the MIC's for Equisetin are 8 ug /mL against Bacillus subtilis, 16 ug /mL against Staphylococcus aureus and Methicillin Resistant Staphylococcus aureus (MRSA). 2. Equisetin specifically inhibits the substrate anion carriers of the mitochondrial inner membrane. 3. Equisetin inhibits the DNP-stimulated ATPase activity of rat liver mitochondria and mitoplasts in a concentration-dependent manner; 50% inhibition is caused by about 8 nmol Equisetin/mg protein. |
Targets | Calcium Channel | ATPase | Antifection | ROS |
Equisetin Dilution Calculator
Equisetin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.6774 mL | 13.3872 mL | 26.7745 mL | 53.549 mL | 66.9362 mL |
5 mM | 0.5355 mL | 2.6774 mL | 5.3549 mL | 10.7098 mL | 13.3872 mL |
10 mM | 0.2677 mL | 1.3387 mL | 2.6774 mL | 5.3549 mL | 6.6936 mL |
50 mM | 0.0535 mL | 0.2677 mL | 0.5355 mL | 1.071 mL | 1.3387 mL |
100 mM | 0.0268 mL | 0.1339 mL | 0.2677 mL | 0.5355 mL | 0.6694 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 4-(Ethoxymethyl)phenol
Catalog No.:BCN4753
CAS No.:57726-26-8
- ent-11alpha-Hydroxy-15-oxokaur-16-en-19-oic acid
Catalog No.:BCN7372
CAS No.:57719-81-0
- 11,15-Dihydroxy-16-kauren-19-oic acid
Catalog No.:BCN1413
CAS No.:57719-76-3
- CGP 7930
Catalog No.:BCC7096
CAS No.:57717-80-3
- Kansuinine A
Catalog No.:BCN3765
CAS No.:57701-86-7
- 2-Acetylbenzoic acid
Catalog No.:BCN5786
CAS No.:577-56-0
- Flavanomarein
Catalog No.:BCN6429
CAS No.:577-38-8
- Kansuinine B
Catalog No.:BCN3766
CAS No.:57685-46-8
- Palmitic acid-1-13C
Catalog No.:BCC8229
CAS No.:57677-53-9
- Baccatin VI
Catalog No.:BCN7229
CAS No.:57672-79-4
- 1-Dehydroxybaccatin IV
Catalog No.:BCN7211
CAS No.:57672-78-3
- Baccatin IV
Catalog No.:BCN5785
CAS No.:57672-77-2
- Nisoxetine hydrochloride
Catalog No.:BCC6894
CAS No.:57754-86-6
- WAY 629 hydrochloride
Catalog No.:BCC7271
CAS No.:57756-44-2
- Cardionogen 1
Catalog No.:BCC6199
CAS No.:577696-37-8
- Topiroxostat
Catalog No.:BCC4202
CAS No.:577778-58-6
- 4-(2-Hydroxy-1-methoxyethyl)-1,2-benzenediol
Catalog No.:BCN1412
CAS No.:577976-26-2
- 8-Aminoquinoline
Catalog No.:BCC8784
CAS No.:578-66-5
- Cosmosiin
Catalog No.:BCN5788
CAS No.:578-74-5
- Liquiritigenin
Catalog No.:BCN5946
CAS No.:578-86-9
- Domperidone
Catalog No.:BCC4461
CAS No.:57808-66-9
- Stevioside
Catalog No.:BCN6305
CAS No.:57817-89-7
- Idarubicin HCl
Catalog No.:BCC1194
CAS No.:57852-57-0
- Clozapine
Catalog No.:BCC5037
CAS No.:5786-21-0
The effect of equisetin on energy-linked reactions in Rhodospirillum rubrum chromatophores.[Pubmed:2536535]
Arch Biochem Biophys. 1989 Feb 1;268(2):659-66.
Light-induced proton uptake, light-induced carotenoid absorbance shift, photophosphorylation, and hydrolysis of Mg-ATP, Ca-ATP, and PPi in Rhodospirillum rubrum chromatophores are shown to be inhibited by the antibiotic Equisetin. The Mg- and Ca-ATPase activities of purified F0F1-ATPase are inhibited by Equisetin. In contrast, only the Ca-ATPase activity of purified F1-ATPase is decreased by Equisetin, whereas the Mg-ATPase is stimulated. Both Equisetin and N,N'-dicyclohexylcarbodiimide (DCCD) inhibit the hydrolytic activity of the purified H+-PPase but not the hydrolytic activity of soluble PPase from R. rubrum and yeast. The I50 for the PPi hydrolysis is near 20 microM for both Equisetin and DCCD. The action of Equisetin on membranes is compared to the effect of Triton X-100 and carbonyl cyanide p-trifluoromethoxyhydrazone. On the basis of these new data, Equisetin is proposed to act nonspecifically on membranes and hydrophobic domains of proteins.
Effects of equisetin on rat liver mitochondria: evidence for inhibition of substrate anion carriers of the inner membrane.[Pubmed:8132493]
J Bioenerg Biomembr. 1993 Oct;25(5):537-45.
The effect of Equisetin, an antibiotic produced by Fusarium equiseti, has been studied on mitochondrial functions (respiration, ATPase, ion transport). Equisetin inhibits the DNP-stimulated ATPase activity of rat liver mitochondria and mitoplasts in a concentration-dependent manner; 50% inhibition is caused by about 8 nmol Equisetin/mg protein. The antibiotic is without effect either on the ATPase activity of submitochondrial particles or on the purified F1-ATPase. It inhibits both the ADP- or DNP-activated oxygen uptake by mitochondria in the presence of glutamate+malate or succinate as substrates, but only the ADP-stimulated respiration is inhibited if the electron donors are TMPD+ascorbate. It does not affect the NADH or succinate oxidation of submitochondrial particles. Equisetin inhibits in a concentration-dependent manner the active Ca(2+)-uptake of mitochondria energized both by ATP or succinate without affecting the Ca(2+)-uniporter itself. The antibiotic inhibits the ATP-uptake by mitochondria (50% inhibition at about 8 nmol Equisetin/mg protein) and the Pi and dicarboxylate carrier. It does not lower the membrane potential at least up to 200 nmol/mg protein concentration. The data presented in this paper indicate that Equisetin specifically inhibits the substrate anion carriers of the mitochondrial inner membrane.
A new enzyme involved in the control of the stereochemistry in the decalin formation during equisetin biosynthesis.[Pubmed:25770422]
Biochem Biophys Res Commun. 2015 May 1;460(2):210-5.
Tetramic acid containing a decalin ring such as Equisetin and phomasetin is one of the characteristic scaffolds found in fungal bioactive secondary metabolites. Polyketide (PKS)-nonribosomal peptide synthetase (NRPS) hybrid enzyme is responsible for the synthesis of the polyketide scaffold conjugated with an amino acid. PKS-NRPS hybrid complex programs to create structural diversity in the polyketide backbone have begun to be investigated, yet mechanism of control of the stereochemistry in a decalin formation via a Diels-Alder cycloaddition remains uncertain. Here, we demonstrate that fsa2, which showed no homology to genes encoding proteins of known function, in the fsa cluster responsible for Equisetin and fusarisetin A biosynthesis in Fusarium sp. FN080326, is involved in the control of stereochemistry in decalin formation via a Diels-Alder reaction in the Equisetin biosynthetic pathway.
Antimicrobial activities of endophytic fungi obtained from the arid zone invasive plant Opuntia dillenii and the isolation of equisetin, from endophytic Fusarium sp.[Pubmed:26160390]
BMC Complement Altern Med. 2015 Jul 10;15:220.
BACKGROUND: Opuntia dillenii is an invasive plant well established in the harsh South-Eastern arid zone of Sri Lanka. Evidence suggests it is likely that the endophytic fungal populations of O. dillenii assist the host in overcoming biotic and abiotic stress by producing biologically active metabolites. With this in mind there is potential to discover novel natural products with useful biological activities from this hitherto poorly investigated source. Consequently, an investigation of the antimicrobial activities of the endophytes of O. dillenii, that occupies a unique ecological niche, may well provide useful leads in the discovery of new pharmaceuticals. METHODS: Endophytic fungi were isolated from the surface sterilized cladodes and flowers of O. dillenii using several nutrient media and the antimicrobial activities were evaluated against three Gram-positive and two Gram-negative bacteria and Candida albicans. The two most bioactive fungi were identified by colony morphology and DNA sequencing. The secondary metabolite of the endophyte Fusarium sp. exhibiting the best activity was isolated via bioassay guided chromatography. The chemical structure was elucidated from the ESIMS and NMR spectroscopic data obtained for the active metabolite. The minimum inhibitory concentrations (MICs) of the active compound were determined. RESULTS: Eight endophytic fungi were isolated from O. dillenii and all except one showed antibacterial activities against at least one of the test bacteria. All extracts were inactive against C. albicans. The most bioactive fungus was identified as Fusarium sp. and the second most active as Aspergillus niger. The structure of the major antibacterial compound of the Fusarium sp. was shown to be the tetramic acid derivative, Equisetin. The MIC's for Equisetin were 8 mug mL(-1) against Bacillus subtilis, 16 mug mL(-1) against Staphylococcus aureus and Methicillin Resistant Staphylococcus aureus (MRSA). CONCLUSIONS: O. dillenii, harbors several endophytic fungi capable of producing antimicrobial substances with selective antibacterial properties. By producing biologically active secondary metabolites, such as Equisetin isolated from the endophytic Fusarium sp., the endophytic fungal population may be assisting the host to successfully withstand stressful environmental conditions. Further investigations on the secondary metabolites produced by these endophytes may provide additional drug leads.
Biomimetic synthesis of equisetin and (+)-fusarisetin A.[Pubmed:24038394]
Chemistry. 2013 Sep 23;19(39):13040-6.
(+)-Fusarisetin A belongs to a group of acyl tetramic acid natural products that show potential anticancer activity. Equisetin, a biogenetically related acyl tetramic acid, contains the basic skeleton of (+)-fusarisetin A. We proposed that Equisetin and (+)-fusarisetin A share a biosynthetic pathway that starts with naturally occurring (S)-serine and an unsaturated fatty acid. In support of this hypothesis, we have demonstrated that a cyclization sequence involving an intramolecular Diels-Alder reaction followed by a Dieckmann cyclization of polyenoylamino acid yielded Equisetin. The aerobic oxidation of Equisetin, promoted by either Mn(III)/O2 or a reactive oxygen species (ROS) produced by visible-light chemistry, gave peroxyfusarisetin, which could be easily reduced to (+)-fusarisetin A. We report herein detailed information on the biogenetic synthesis of Equisetin and (+)-fusarisetin A.